---
schema_version: "secwatch.filing_event.v1"
accession: "0001601485-25-000018"
form_type: "8-K"
ticker: "ELTX"
cik: "0001601485"
company_name: "Elicio Therapeutics, Inc."
filed_at: "2025-03-05T23:59:59+00:00"
generated_at: "2026-05-25T10:25:46.876408+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Elicio Therapeutics (ELTX) settles $20M convertible note, issues 3.5M shares

## Summary
- Converted $20M 3.0% Senior Secured Convertible Note due Feb 2026 into 3,500,573 common shares on March 5, 2025.
- Shares issued to GKCC, LLC, an entity controlled by a board member; exemption under Section 3(a)(9) of Securities Act.
- Conversion triggered by stock price closing at or above 135% of $5.81 conversion price for 20 of 30 trading days.
- Post-conversion shares outstanding increased to 15,861,913, diluting prior holders by approximately 28%.
- Note originally issued in August 2024; conversion eliminates remaining principal and accrued interest.

## SEC filing metadata
- accession: 0001601485-25-000018
- form_type: 8-K
- ticker: ELTX
- cik: 0001601485
- company_name: Elicio Therapeutics, Inc.
- filed_at: 2025-03-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601485/000160148525000018/0001601485-25-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601485/000160148525000018/angn-20250305.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601485-25-000018
- JSON: https://secwatch.observer/filing/0001601485-25-000018.json
- Plain text: https://secwatch.observer/filing/0001601485-25-000018.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.